These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2257294)

  • 1. Benzylacyclouridine reverses azidothymidine-induced marrow suppression without impairment of anti-human immunodeficiency virus activity.
    Calabresi P; Falcone A; St Clair MH; Wiemann MC; Chu SH; Darnowski JW
    Blood; 1990 Dec; 76(11):2210-5. PubMed ID: 2257294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different effect of benzylacyclouridine on the toxic and therapeutic effects of azidothymidine in mice.
    Falcone A; Darnowski JW; Ruprecht RM; Chu SH; Brunetti I; Calabresi P
    Blood; 1990 Dec; 76(11):2216-21. PubMed ID: 2257295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term bone marrow stromal and hemopoietic toxicity to AZT: protective role of heme and IL-1.
    Abraham NG; Chertkov JL; Staudinger R; Jiang S; Lutton JD; Argani I; Levere RD; Kappas A
    Exp Hematol; 1993 Feb; 21(2):263-8. PubMed ID: 7678812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue-specific expansion of uridine pools in mice. Effects of benzylacyclouridine, dipyridamole and exogenous uridine.
    Darnowski JW; Handschumacher RE; Wiegand RA; Goulette FA; Calabresi P
    Biochem Pharmacol; 1991 Jun; 41(12):2031-6. PubMed ID: 2039551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of oral uridine as a substitute for parenteral uridine rescue of 5-fluorouracil therapy, with and without the uridine phosphorylase inhibitor 5-benzylacyclouridine.
    Martin DS; Stolfi RL; Sawyer RC
    Cancer Chemother Pharmacol; 1989; 24(1):9-14. PubMed ID: 2720896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uridine reverses the toxicity of 3'-azido-3'-deoxythymidine in normal human granulocyte-macrophage progenitor cells in vitro without impairment of antiretroviral activity.
    Sommadossi JP; Carlisle R; Schinazi RF; Zhou Z
    Antimicrob Agents Chemother; 1988 Jul; 32(7):997-1001. PubMed ID: 3190201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamins C and E prevent AZT-induced leukopenia and loss of cellularity in bone marrow. Studies in mice.
    García-de-la-Asunción J; Gómez-Cambronero LG; Del Olmo ML; Pallardó FV; Sastre J; Viña J
    Free Radic Res; 2007 Mar; 41(3):330-4. PubMed ID: 17364962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inhibition of human immunodeficiency virus replication by azidothymidine (Azitidín Lachema) in cultured cells].
    Schmidtmayerová H; Mayer V
    Bratisl Lek Listy; 1993 Feb; 94(2):76-80. PubMed ID: 7689030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-human immunodeficiency virus synergism by zidovudine (3'-azidothymidine) and didanosine (dideoxyinosine) contrasts with their additive inhibition of normal human marrow progenitor cells.
    Dornsife RE; St Clair MH; Huang AT; Panella TJ; Koszalka GW; Burns CL; Averett DR
    Antimicrob Agents Chemother; 1991 Feb; 35(2):322-8. PubMed ID: 1708977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcutaneous recombinant granulocyte-macrophage colony-stimulating factor used as a single agent and in an alternating regimen with azidothymidine in leukopenic patients with severe human immunodeficiency virus infection.
    Pluda JM; Yarchoan R; Smith PD; McAtee N; Shay LE; Oette D; Maha M; Wahl SM; Myers CE; Broder S
    Blood; 1990 Aug; 76(3):463-72. PubMed ID: 2198957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of protein A-induced amelioration of toxicity of anti-AIDS drug, zidovudine.
    Subbulakshmi V; Ghosh AK; Das T; Ray PK
    Biochem Biophys Res Commun; 1998 Sep; 250(1):15-21. PubMed ID: 9735323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benzylacyclouridine. Pharmacokinetics, metabolism and biochemical effects in mice.
    Darnowski JW; Handschumacher RE
    Biochem Pharmacol; 1988 Jul; 37(13):2613-8. PubMed ID: 3390221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of combination interleukin-3 (IL-3) and granulocyte-macrophage colony stimulating factor (GM-CSF) on hematopoiesis administered to retrovirus-infected immunodeficient mice receiving dose-escalation zidovudine (AZT).
    Gallicchio VS; Hughes NK; Tse KF; Ling J; Gaines H; Bowen TE; Uluitu M
    Int J Immunopharmacol; 1995 Nov; 17(11):865-78. PubMed ID: 8788116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microenvironmental toxicity of azidothymidine: partial sparing with hemin.
    Abraham NG; Bucher D; Niranjan U; Brown AC; Lutton JD; Distenfeld A; Ahmed T; Levere RD
    Blood; 1989 Jul; 74(1):139-44. PubMed ID: 2752105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time-dependent changes induced by azidothymidine in erythroid progenitor colonies in immunodeficient mice.
    Chow FP; Hamburger AW
    Exp Hematol; 1992 Feb; 20(2):245-50. PubMed ID: 1544395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2'-Deoxycytidine protects normal human bone marrow progenitor cells in vitro against the cytotoxicity of 3'-azido-3'-deoxythymidine with preservation of antiretroviral activity.
    Bhalla K; Birkhofer M; Li GR; Grant S; MacLaughlin W; Cole J; Graham G; Volsky DJ
    Blood; 1989 Nov; 74(6):1923-8. PubMed ID: 2572282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of interleukin-1, GM-CSF, erythropoietin, and lithium on the toxicity associated with 3'-azido-3'-deoxythymidine (AZT) in vitro on hematopoietic progenitors (CFU-GM, CFU-MEG, and BFU-E) using murine retrovirus-infected hematopoietic cells.
    Gallicchio VS; Hughes NK; Hulette BC; Noblitt L
    J Leukoc Biol; 1991 Dec; 50(6):580-6. PubMed ID: 1940611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity of erythroid progenitor colonies to erythropoietin in azidothymidine treated immunodeficient mice.
    Chow FP; Sutton PA; Hamburger AW
    Br J Haematol; 1991 Feb; 77(2):139-44. PubMed ID: 2004015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of 5-benzylacyclouridine, an inhibitor of uridine phosphorylase, on the pharmacokinetics of uridine in rhesus monkeys: implications for chemotherapy.
    Sommadossi JP; Cretton EM; Kidd LB; McClure HM; Anderson DC; el Kouni MH
    Cancer Chemother Pharmacol; 1995; 37(1-2):14-22. PubMed ID: 7497584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.